Molecular Response (PDX business unit) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Molecular Response (PDX business unit) General Information

Description

Provider of translational oncology drug discovery services. The unit provides PDX models as well as 8000 viable human tumors for model development services.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • San Diego, CA 92121
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Molecular Response (PDX business unit) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Molecular Response (PDX business unit)‘s full profile, request access.

Request a free trial

Molecular Response (PDX business unit) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Molecular Response (PDX business unit)‘s full profile, request access.

Request a free trial